Sarepta Therapeutics shares plunge as gene therapy trial falls short of primary goal
October 31, 2023 at 07:25 AM EDT
Company plans to seek label expansion for Duchenne muscular dystrophy treatment
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|